You don't have javascript enabled. Please enable javascript for full site funcionality.
Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
Clinical Research and Public Health
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
ASCI Milestone Awards
Video Abstracts
Conversations with Giants in Medicine
Reviews
Reviews
View all reviews ...
Review Series
The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
Neurodegeneration (Mar 2026)
Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
Pancreatic Cancer (Jul 2025)
Complement Biology and Therapeutics (May 2025)
Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
Microbiome in Health and Disease (Feb 2025)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Research and Public Health
Research Letters
Letters to the Editor
Editorials
Commentaries
Editor's notes
Reviews
Viewpoints
100th anniversary
Top read articles
Conversations With Giants In Medicine
80 Articles
80 Posts
← Previous
1
2
3
…
7
8
Next →
Ending one conversation, starting another
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
Ending one conversation, starting another
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Zhijian (James) Chen
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Zhijian (James) Chen
Text
PDF
Abstract
Authors
Ushma S. Neill
×
Conversations with JCI editors in chief
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
Conversations with JCI editors in chief
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Stanley Prusiner
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Stanley Prusiner
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Elias Zerhouni
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Elias Zerhouni
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Olufunmilayo Olopade
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Olufunmilayo Olopade
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Peter Hotez
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Peter Hotez
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Elizabeth Jaffee
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Elizabeth Jaffee
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Katherine High
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Katherine High
Text
PDF
Abstract
Authors
Ushma S. Neill
×
A conversation with Jeffrey Whitsett
Ushma S. Neill
Ushma S. Neill
View:
Text
|
PDF
A conversation with Jeffrey Whitsett
Text
PDF
Abstract
Authors
Ushma S. Neill
×
← Previous
1
2
3
…
7
8
Next →
← Previous
1
2
…
5
6
7
8
Next →
David Nathan
David Nathan, professor at Harvard Medical School and President Emeritus of the Dana-Farber Cancer Institute, is a renowned hematologist with contributions to the clinical treatments of β-thalassemia, sickle cell disease, and chronic granulomatous disease.
Published December 2, 2014
Conversations with Giants in Medicine
Peter Agre
Peter Agre was awarded the 2003 Nobel Prize for the discovery of aquaporins. He is currently the director of the Johns Hopkins Malaria Research Institute.
Published November 3, 2014
Conversations with Giants in Medicine
Twenty-six compelling conversations
Since May 2012, the JCI has aired twenty-six interviews with twenty-eight notable scientists for the series Conversations with Giants in Medicine.
Published October 1, 2014
Conversations with Giants in Medicine
Lasker Giants
For the last five years, the JCI has had the privilege of working with the Albert and Mary Lasker Foundation to write profiles on the prizewinners. Coverage of the 2014 laureates will be featured in the October issue. In addition to the news feature...
Published September 2, 2014
Conversations with Giants in Medicine
Napoleone Ferrara
Napoleone Ferrara, of the University of California, San Diego, is best known for isolating and cloning vascular endothelial growth factor (VEGF). He then built the humanized monoclonal antibody against VEGF that led to the blockbuster drugs Avastin ...
Published August 26, 2014
Conversations with Giants in Medicine
Tony Fauci
Tony Fauci is the Director of the National Institute of Allergy and Infectious Diseases within the NIH. His work on HIV is at the forefront of infectious disease research, and he is the leader of the national discussion of infectious disease pandemi...
Published July 1, 2014
Conversations with Giants in Medicine
P. Roy Vagelos
The biochemist P. Roy Vagelos is best known for leading Merck for 20 years, first as President of research and then later as CEO and Chairman of the Board. In his time at Merck, he revolutionized the way the company approached drug discovery, introd...
Published June 2, 2014
Conversations with Giants in Medicine
Bonnie Bassler
Bonnie Bassler of Princeton University and the Howard Hughes Medical Institute has revolutionized the way that we think about microbiology. She elucidated the chemical language that bacteria use to communicate through a process called quorum sensing...
Published April 1, 2014
Conversations with Giants in Medicine
Don Ganem
After a 15-year focus on the biology of the hepatitis B virus (HBV) family, the modern-day microbe hunter Don Ganem turned his attention to KSHV, the herpes virus that is the cause of the AIDS-related neoplasm Kaposi sarcoma (KS). His lab at UCSF wa...
Published February 3, 2014
Conversations with Giants in Medicine
Marc Feldmann
Sir Marc Feldmann’s research over the last 30 years has focused on the understanding of autoimmune disease, specifically the treatment of rheumatoid arthritis (RA). Sir Marc, now at the Kennedy Institute of Rheumatology at Oxford University, c...
Published January 2, 2014
Conversations with Giants in Medicine
← Previous
1
2
…
5
6
7
8
Next →
Advertisement
